SEC Form 4 · accession 0001209191-17-029213

NEOGENOMICS INC · NEO

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Officer — Chief Financial Officer

Period of report

Apr 28, 2017

Accepted (ET)

May 2, 2017 · 4:35 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001077183

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
Common Stock	holding	—	—		—	189,089	D
Common Stock	holding	—	—		—	20,000	I	Trust by Self

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F4	$7.52	Apr 28, 2017	A	200,000	A	Apr 28, 2018	Apr 28, 2022	Common Stock	200,000	200,000	D
Stock Option (Right to Buy)^F1	$3.45	holding	—	—	—	Mar 5, 2015	Mar 5, 2019	Common Stock	30,000	30,000	D
Stock Option (Right to Buy)^F2	$4.78	holding	—	—	—	May 4, 2016	May 4, 2020	Common Stock	200,000	200,000	D
Stock Option (Right to Buy)^F3	$7.15	holding	—	—	—	Apr 20, 2017	Apr 20, 2021	Common Stock	200,000	200,000	D

F1On March 5, 2014 Mr. Cardoza was granted an option to purchase 30,000 shares. These options vest ratably over the first three anniversary dates of the grant.
F2On May 4, 2015 Mr. Cardoza was granted an option to purchase 200,000 shares. These options vest ratably over the first three anniversary dates of the grant.
F3On April 20, 2016, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the first three anniversary dates of the grant date.
F4On April 28, 2017, Mr. Cardoza was granted 200,000 stock options. These options vest ratably over the next three anniversary dates of the grant date.